Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion

NCT07002476 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

652

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: guideline-recommended SoC
DRUG: Recaticimab (intensive)

Sponsor

Shanghai East Hospital